Latitude Advisors, LLC Sanofi Transaction History

Latitude Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$48.99 - $57.46 $519,930 - $609,822	-10,613 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$48.48 - $53.65 $128,520 - $142,226	2,651 Added 33.3%	10,613 $545,000
Q4 2021 Jan 18, 2022	SELL	$47.07 - $52.35 $188 - $209	-4 Reduced 0.05%	7,962 $399,000
Q3 2021 Oct 14, 2021	BUY	$47.89 - $53.12 $197,211 - $218,748	4,118 Added 107.02%	7,966 $384,000
Q2 2021 Jul 20, 2021	BUY	$49.36 - $54.25 $189,937 - $208,754	3,848 New	3,848 $203,000
Q1 2021 Apr 14, 2021	SELL	$45.46 - $50.51 $474,147 - $526,819	-10,430 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$45.3 - $51.62 $472,478 - $538,396	10,430 New	10,430 $507,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Latitude Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Latitude Advisors, LLC with notifications on news.